{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicqfidi5txlfl42t32b5xmktbw76ogm24iha352olnyuz7qh4yssy",
    "uri": "at://did:plc:ao3t7cr3n5vz5lhwlje3oied/app.bsky.feed.post/3mm4pzvbcqhx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif4c3ybotiepsutpvy4oy5fg2p7elrj4bonb7t2cyooptgbfzid2m"
    },
    "mimeType": "image/jpeg",
    "size": 60339
  },
  "path": "/story/car-t-therapy-may-help-control-hiv-long-term/",
  "publishedAt": "2026-05-18T10:30:00.000Z",
  "site": "https://www.wired.com",
  "tags": [
    "Science",
    "Science / Health",
    "HIV",
    "health",
    "medicine",
    "diseases",
    "Super Cells"
  ],
  "textContent": "CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.",
  "title": "Supercharging Immune Cells May Help Control HIV Long-Term"
}